Medtronic has received CE mark for its Endurant II/IIs stent graft system to treat abdominal aortic aneurysm patients using a ChEVAR procedure—a parallel graft chimney technique that uses commercially available balloon expandable covered stents combined with a standard aortic stent graft.
A new vascular medicine registry will be launched in early 2017 by the Society for Vascular Surgery (SVS) and the Society for Vascular Medicine (SVM).
Lombard Medical has announced positive long-term data providing confirmation of sustained performance for its Aorfix endovascular stent graft system in the most challenging anatomies.
Teleflex is to acquire Vascular Solutions in a transaction valued at approximately US$1 billion. Under the terms of the agreement, Teleflex will acquire all of the issued and outstanding shares of Vascular Solutions common stock for US$56 per share, in cash.
In November 2016, Bentley launched its BeGraft aortic stent graft system: a balloon expandable, large diameter covered stent with sizes ranging from 12mm to 24mm available in lengths of 19mm to 59mm.
A new study published in the New England Journal of Medicine has shown that surgeons in England operate significantly less often on aortic aneurysms in the population than US surgeons, and that the English death rate for the condition is over twice that in the USA.
“Systematic scrutiny” of the large patient cohort in the PERICLES registry has resulted in a new classification describing three distinct patterns of chimney endovascular aneurysm repair (chEVAR) gutter-related endoleaks and technical modifications for their treatment, according to an article published in the Journal of Endovascular Therapy.
Shockwave Medical has announced the closing of US$45 million in Series C financing led by Sectoral Asset Management, with participation from mutual funds advised by T Rowe Price Associates and returning investors including Sofinnova Partners, Venrock, RA Capital, Deerfield, Ally Bridge Group and others.
Spectranetics’ Stellarex 0.014” drug-coated angioplasty balloon has received the CE mark.
Clinical data presented at the 2016 VEITH symposium (New York City, USA) of the global Ovation Pivotal Trial has revealed positive five-year safety and effectiveness for the Endologix Ovation system.
LimFlow has received CE mark for its fully percutaneous LimFlow system designed for venous arterialisation of the lower limbs in end-stage patients at risk of limb amputation for critical limb ischaemia.
Gore joined with leaders across the vascular and endovascular community in honouring five North American physicians as Pioneers in Performance. The biennial awards programme acknowledges exceptional work in the field of vascular and endovascular therapy, including aortic and lower limb bypass and dialysis access surgery.
Lombard Medical has announced that its Altura endovascular stent graft system was featured in a scientific presentation at the VEITHsymposium in New York, USA, on 17 November 2016. The Altura stent graft, which was launched commercially in Europe earlier in 2016, is specifically designed to simplify treatment in patients with normal abdominal aortic aneurysm anatomy.
Aortica Corporation has announced that Benjamin Starnes, chief of Vascular Surgery at the University of Washington, completed the first three-vessel fenestrated endovascular aneurysm repair (FEVAR) using Aortica’s AortaFit investigational automated case planning software and Bolton Medical’s Treo abdominal stent graft system as part of his physician-sponsored IDE study.
Data from Endologix’ Global Registry have found 98% freedom from persistent endoleaks with its Nellix system at two-year follow-up, among other positive results. The patient cohort—of which over one-third exhibited complex anatomies—also experienced strong aneurysm and cardiovascular-related mortality results and zero secondary interventions for Type II endoleaks.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos